相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis
Heba Dosoki et al.
EXPERIMENTAL DERMATOLOGY (2017)
Oxidative stress markers in blood in systemic sclerosis: A meta-analysis
Jing-Ying Luo et al.
MODERN RHEUMATOLOGY (2017)
Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma
Miao Jiang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Diagnosis and Management of Systemic Sclerosis: A Practical Approach
Jason J. Lee et al.
DRUGS (2016)
Oxidative stress parameters in localized scleroderma patients
F. Kilinc et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
Changes in lymphocyte properties after employment of the combination of carbamylation and oxidative stress, an in vitro study
Anna Pieniazek et al.
TOXICOLOGY IN VITRO (2016)
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis
Alexandre T. J. Maria et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
Christopher R. Pasarikovski et al.
ARTHRITIS RESEARCH & THERAPY (2016)
High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis
Khalil Bourji et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Propylthiouracil modulates aortic vasculopathy in the oxidative stress model of systemic sclerosis
Gianluca Bagnato et al.
VASCULAR PHARMACOLOGY (2015)
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2
Donatella Amico et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Role of Cellular Senescence and NOX4-Mediated Oxidative Stress in Systemic Sclerosis Pathogenesis
Sonsoles Piera-Velazquez et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis
Bogna Grygiel-Gorniak et al.
MEDIATORS OF INFLAMMATION (2014)
Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
Devi Kundu et al.
VASCULAR PHARMACOLOGY (2014)
Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts
Pei-Suen Tsou et al.
ARTHRITIS AND RHEUMATISM (2012)
Red Blood Cell Alterations in Systemic Sclerosis: a Pilot Study
Antonello Giovannetti et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants
Audrey Dooley et al.
CARDIOLOGY RESEARCH AND PRACTICE (2012)
EVALUATION OF THE EFFECT OF BOSENTAN TREATMENT ON PROINFLAMMATORY CYTOKINE SERUM LEVELS IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS
F. Bellisai et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Promotion of plasma membrane repair by vitamin E
Amber C. Howard et al.
NATURE COMMUNICATIONS (2011)
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts
Stefano Soldano et al.
NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES: TRANSLATION FROM BASICS TO CLINICS (2010)
Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage
Fumihide Ogawa et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
High DNA Oxidative Damage in Systemic Sclerosis
Jerome Avouac et al.
JOURNAL OF RHEUMATOLOGY (2010)
The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients
Edoardo Rosato et al.
CLINICAL RHEUMATOLOGY (2009)
Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse
Amelie Servettaz et al.
JOURNAL OF IMMUNOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antioxidant defense capacity in scieroderma patients
Roxana Sfrent-Cornateanu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Redox state and gender differences in vascular smooth muscle cells
Walter Malorni et al.
FEBS LETTERS (2008)
Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis
Erdinc Devrim et al.
MEDICAL PRINCIPLES AND PRACTICE (2008)
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
Valeria Riccieri et al.
CLINICAL RHEUMATOLOGY (2008)
Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis
A. Servettaz et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress
Y. Iwata et al.
RHEUMATOLOGY (2007)
The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease
Cynthia M. Magro et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis
F. Ogawa et al.
RHEUMATOLOGY (2006)
Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies
S. Sohail Ahmed et al.
ARTHRITIS AND RHEUMATISM (2006)
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine
A. Dooley et al.
RHEUMATOLOGY (2006)
Lipid peroxidation and trace elements in systemic sclerosis
M Tikly et al.
CLINICAL RHEUMATOLOGY (2006)
Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation
S Christen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Endothelin-1 in congenital heart disease
M Beghetti et al.
PEDIATRIC RESEARCH (2005)
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
RH Boger et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Effects of short-term treatment with vitamin E in systemic sclerosis: a double-blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement
JL Cracowski et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma
M Nagai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Correlation between serum E-selectin levels and panoramic nailfold capillaroscopy in systemic sclerosis
V Valim et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Systemic and cell type-specific gene expression patterns in scleroderma skin
ML Whitfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis
ME Mavrikakis et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2003)
Necessary role of phosphatidylinositol 3-kinase in transforming growth factor β-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts
G Kim et al.
ARTHRITIS AND RHEUMATISM (2002)
The isoprostane 8-iso-PGF2α stimulates endothelial cells to bind monocytes:: differences from thromboxane-mediated endothelial activation
N Leitinger et al.
FASEB JOURNAL (2001)
分享论文
